Indication
Blood sugar
7 clinical trials
9 products
2 drugs
Clinical trial
A Randomised, Multiple-Dose, Single Period, Phase II/III Dose Response Study to Examine Transdermal Human Insulin in Adult Diabetic PatientsStatus: Not yet recruiting, Estimated PCD: 2024-12-15
Product
Human InsulinClinical trial
A 24-week, Multi-center, Randomized, Open-Label Clinical Trial to Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes (XTREME Study)Status: Completed, Estimated PCD: 2024-04-02
Product
XuezhikangProduct
AtorvastatinClinical trial
Regulation of Endogenous Glucose Production by Central KATP ChannelsStatus: Recruiting, Estimated PCD: 2027-04-01
Product
DiazoxideProduct
Nicotinic acidDrug
VarlilumabClinical trial
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal ToleranceStatus: Recruiting, Estimated PCD: 2024-08-31
Product
Kisspeptin-10Clinical trial
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusStatus: Recruiting, Estimated PCD: 2025-02-23
Product
LiraglutideProduct
SemaglutideDrug
MetforminClinical trial
The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant RecipientsStatus: Withdrawn, Estimated PCD: 2023-04-21
Product
PlaceboClinical trial
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to DiazoxideStatus: , Estimated PCD: 2024-08-01